Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches
The cardiovascular system transports oxygen and nutrients to all parts of the body; therefore, any impediment to this system through, for example, a circulatory disorder, represents a serious threat to organs, tissues, and cells. Obstructive diseases of vessels with a diameter of more than 1 mm can...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Tokyo :
Springer Tokyo,
2005.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Vascular Precursor Cells and Their Potentiation
- EPC and Their Potentiation by Adenovirus Gene Delivery
- Potentiation of Regenerative Therapy by Non-Viral Vector, Gelatin Hydrogel
- Regeneration of Myocardium Using Bone Marrow Cells
- Development of Myocardial Sheets and Their Cell Sources
- Cell Sheet Technology for Myocardial Tissue Engineering
- Myocardial Regeneration Therapy with Tissue Implantation of Autologous Myoblast Sheets for Severe Impaired Heart Failure
- Cardiovascular Cell Differentiation from ES Cells
- Hybrid Tissues
- Preparation and Recellularization of Tissue Engineered Bioscaffold for Heart Valve Replacement
- Biotube Technology for a Novel Tissue-Engineered Blood Vessels
- Clinical Application of Tissue-Engineered Blood Vessels
- New Aspects of Angiogenesis
- Vascular Regeneration and Remodeling by Circulating Progenitor Cells
- Gene Therapy with Hepatocyte Growth Factor for Angiogenesis in Severe Pulmonary Vascular Disease
- Basic Fibroblast Growth Factor and Angiogenesis
- Gene Therapy for Angiogenesis under a Ventricular Assist System
- The Role of Vascular Endothelial Growth Factor (VEGF) on Therapeutic Angiogenesis Using Bone Marrow Cells
- Clinical Results of Therapeutic Angiogenesis and Vasculogenesis
- Clinical Survey of Cell Therapy in Japan
- A Novel Micro-Angiography Detecting Angiogenesis, Application for Autologous Bone Marrow Mononuclear Cells Transplantation in the Patients with Critical Limb Ischemia
- Angiogenesis Induced by Intramyocardial Implantation of Autologous Bone Marrow Mononuclear Cells for the Treatment of Ischemic Heart Disease
- Effect of Bone Marrow Transplantation in Patients with Critical Limb Ischemia
- Therapeutic Angiogenesis for a Patient with Arteriosclerosis Obliterans by Autologous Transplantation of Bone Marrow Mononuclear Cells
- Autologous Bone Marrow Implantation for Buerger’s Disease.
